The National Center for Advancing Translational Sciences announced two new funding opportunities focused on clinical trial readiness in rare diseases:
Mathieu Lemaire, MSc, MDCM, PhD, FRCP(C), FAAP, and his research team at The Hospital for Sick Children in Toronto are conducting an international survey of physicians who treat individuals with TSC.
2017 was a very productive year for advancing the science of tuberous sclerosis complex (TSC)! A very small sampling of our scientific community’s major accomplishments are highlighted below. The TS Alliance thanks all our grantees, collaborators, reviewers, conference attendees, International Scientific Advisory Board members, and Professional Advisory Board members for making these achievements possible.
The Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Complex (PREVeNT) trial, led by Martina Bebin at the University of Alabama Birmingham, is continuing to enroll participants at seven sites across the country.